0001894562-23-000026.txt : 20230616 0001894562-23-000026.hdr.sgml : 20230616 20230616174948 ACCESSION NUMBER: 0001894562-23-000026 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230614 FILED AS OF DATE: 20230616 DATE AS OF CHANGE: 20230616 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Foster-Cheek Kaye I CENTRAL INDEX KEY: 0001312622 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41536 FILM NUMBER: 231022540 MAIL ADDRESS: STREET 1: JOHNSON & JOHNSON STREET 2: ONE JOHNSON & JOHNSON PLAZA CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Prime Medicine, Inc. CENTRAL INDEX KEY: 0001894562 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21 ERIE ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-465-0013 MAIL ADDRESS: STREET 1: 21 ERIE ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 wf-form4_168695217738921.xml FORM 4 X0407 4 2023-06-14 0 0001894562 Prime Medicine, Inc. PRME 0001312622 Foster-Cheek Kaye I C/O PRIME MEDICINE, INC. 21 ERIE STREET CAMBRIDGE MA 02139 1 0 0 0 0 Stock Option (right to buy) 14.83 2023-06-14 4 A 0 39062 0 A 2033-06-14 Common Stock 39062.0 39062 D The shares subject to this option shall vest in full upon the earlier of (i) June 14, 2024 or (ii) the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date. /s/ Gabriela Morales-Rivera, attorney-in-fact 2023-06-16